Whole-body diffusion-weighted imaging in lymphoma

por Lin, C., Itti, E., Luciani, A., Haioun, C., Meignan, M., Rahmouni, A.
Publicado 2010

Lymphoma: imaging in the evaluation of residual masses

por Rahmouni, A., Divine, M., Kriaa, S., Haïoun, C., Anglade, M.-C., Kobeiter, H.
Publicado 2015

MRI and PET of bone marrow in lymphoproliferative diseases

por Rahmouni, A., Meignan, M., Divine, M., Luciani, A., Haioun, C., Montazel, J.-L., Kobeiter, H.
Publicado 2015

Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.

por Morel, P., Dupriez, B., Herbrecht, R., Bastion, Y., Tilly, H., Delannoy, A., Haioun, C., Nouvel, C., Bouabdallah, K., Baumelou, E.
Publicado 1994

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study

por Zinzani, P. L., Vose, J. M., Czuczman, M. S., Reeder, C. B., Haioun, C., Polikoff, J., Tilly, H., Zhang, L., Prandi, K., Li, J., Witzig, T. E.
Publicado 2013

EZH2 alterations in follicular lymphoma: biological and clinical correlations

por Huet, S, Xerri, L, Tesson, B, Mareschal, S, Taix, S, Mescam-Mancini, L, Sohier, E, Carrère, M, Lazarovici, J, Casasnovas, O, Tonon, L, Boyault, S, Hayette, S, Haioun, C, Fabiani, B, Viari, A, Jardin, F, Salles, G
Publicado 2017

PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS ST...

por Borchmann, P., Vandenberghe, P., Urbano, A., Haioun, C., Lemonnier, F., Griškevicius, L., Maury, S., Holtkamp, S., Friedrichs, B., Zadoyan, G., Hanssens, L., Brillant, C., Bethke, U., Assenmacher, M., Bürger, I., Philippe, B., Overstijns, T., Jäger, U., Kersten, M. J.
Publicado 2022

P1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE L...

por McMillan, A., Haioun, C., Sancho, J.-M., Viardot, A., Rodriguez Izquierdo, A., Donato Martin, E. M., García-Sancho, A. M., Sandoval-Sus, J., Tilly, H., Vandenberghe, E., Hirata, J., Choudhry, P., Chang, Y. M., Musick, L., Matasar, M.
Publicado 2022

P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY

por Trněný, M., Fogliatto, L., Gardner, F., Flinn, I., Larouche, J.-F., Haioun, C., Canales, M., Goto, H., Hajek, R., Salles, G., Qiu, J., Campinha-Bacote, A., Yan, M., Kothari, R., Man, G., Sahin, D., Hirata, J., Lee, C., Tilly, H., Flowers, C.
Publicado 2022

P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE II...

por Cartron, G., Bachy, E., Tilly, H., Daguindau, N., Pica, G.-M., Bijou, F., Mounier, C., Clavert, A. M., Damaj, G. L., Slama, B., Casasnovas, O., Houot, R., Bouabdallah, K., Sibon, D., Fitoussi, O., Morineau, N., Herbaux, C., Gastinne, T., Fornecker, L.-M., Haioun, C., Launay, V., Araujo, C., Benbrahim, O., Sanhes, L., Gressin, R., Gonzalez, H., Morschhauser, F., Xerri, L., Tarte, K., Pranger, D.
Publicado 2022

P1186: A LARGE FRENCH REAL WORLD MULTICENTRIC PROSPECTIVE COHORT OF PATIENTS WITH LYMPHOMA (REALYSA STUDY): DESCRIPTION OF THE DIFFUSE LARGE B CELL LYMPHOMA PATIENTS IN REAL WORLD...

por Ghesquieres, H., Cherblanc, F., Belot, A., Camus, V., Thokagevistk, K., Bouabdallah, K.-K., Esnault, C., Fornecker, L.-M., Micon, S., Bijou, F., Haioun, C., Morineau, N., Ysebaert, L., Damaj, G., Le Gouill, S., Guidez, S., Morschhauser, F., Thiéblemont, C., Chauchet, A., Gressin, R., Jardin, F., Fruchart, C., Labouré, G., Fouillet, L., Lionne-Huyghe, P., Bonnet, A., Lebras, L., Amorim, S., Leyronnas, C., Olivier, G., Guieze, R., Lamy, T., Launay, V., Drenou, B., Fitoussi, O., Detourmignies, L., Abraham, J., Soussain, C., Lachenal, F., Fogarty, P., Cony-Makhoul, P., Bernier, A., Le Guyader-Peyrou, S., Monnereau, A., Boissard, F., Rossi, C.
Publicado 2022